These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 12913921

  • 1. Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study.
    Berthelot JM, Saulquin X, Coste-Burel M, Peyrat MA, Echasserieau K, Bonneville M, Houssaint E.
    J Rheumatol; 2003 Aug; 30(8):1673-9. PubMed ID: 12913921
    [Abstract] [Full Text] [Related]

  • 2. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
    Blaschke S, Schwarz G, Moneke D, Binder L, Müller G, Reuss-Borst M.
    J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
    [Abstract] [Full Text] [Related]

  • 4. Epitope specificity of clonally expanded populations of CD8+ T cells found within the joints of patients with inflammatory arthritis.
    Fazou C, Yang H, McMichael AJ, Callan MF.
    Arthritis Rheum; 2001 Sep; 44(9):2038-45. PubMed ID: 11592365
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.
    Vogl BA, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs WJ.
    J Med Virol; 2012 Jan; 84(1):119-31. PubMed ID: 22095540
    [Abstract] [Full Text] [Related]

  • 6. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
    Macedo C, Donnenberg A, Popescu I, Reyes J, Abu-Elmagd K, Shapiro R, Zeevi A, Fung JJ, Storkus WJ, Metes D.
    Transpl Immunol; 2005 Jun; 14(2):109-16. PubMed ID: 15935301
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus and rheumatoid arthritis.
    Balandraud N, Roudier J, Roudier C.
    Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G, Hamidou MA, Clémenceau B, Gaschet J, Tiberghien P, Ferrand C, Vivien R, Barbarot S, Coste-Burel M, Moreau A, Vié H.
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [Abstract] [Full Text] [Related]

  • 11. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 12. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.
    Woodberry T, Suscovich TJ, Henry LM, Davis JK, Frahm N, Walker BD, Scadden DT, Wang F, Brander C.
    J Infect Dis; 2005 Nov 01; 192(9):1513-24. PubMed ID: 16206065
    [Abstract] [Full Text] [Related]

  • 13. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K.
    J Infect Dis; 2004 Sep 01; 190(5):985-8. PubMed ID: 15295706
    [Abstract] [Full Text] [Related]

  • 14. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells.
    Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, di Pede P, Lucchini G, Zanlari L, Passeri G, Zanni F, Chezzi C, Franceschi C, Sansoni P.
    Exp Gerontol; 2004 Aug 01; 39(8):1233-43. PubMed ID: 15288697
    [Abstract] [Full Text] [Related]

  • 15. Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis.
    Balandraud N, Guis S, Meynard JB, Auger I, Roudier J, Roudier C.
    Arthritis Rheum; 2007 Jun 15; 57(5):762-7. PubMed ID: 17530675
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A, Wada T, Sakakibara Y, Mase S, Araki R, Tone Y, Toma T, Kurokawa T, Yanagisawa R, Tamura K, Nishida N, Taneichi H, Kanegane H, Yachie A.
    J Infect Dis; 2010 Jun 15; 201(12):1923-32. PubMed ID: 20443735
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
    Clave E, Agbalika F, Bajzik V, Peffault de Latour R, Trillard M, Rabian C, Scieux C, Devergie A, Socié G, Ribaud P, Adès L, Ferry C, Gluckman E, Charron D, Esperou H, Toubert A, Moins-Teisserenc H.
    Transplantation; 2004 Jan 15; 77(1):76-84. PubMed ID: 14724439
    [Abstract] [Full Text] [Related]

  • 18. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope.
    Saal JG, Krimmel M, Steidle M, Gerneth F, Wagner S, Fritz P, Koch S, Zacher J, Sell S, Einsele H, Müller CA.
    Arthritis Rheum; 1999 Jul 15; 42(7):1485-96. PubMed ID: 10403278
    [Abstract] [Full Text] [Related]

  • 19. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.
    Tan LC, Gudgeon N, Annels NE, Hansasuta P, O'Callaghan CA, Rowland-Jones S, McMichael AJ, Rickinson AB, Callan MF.
    J Immunol; 1999 Feb 01; 162(3):1827-35. PubMed ID: 9973448
    [Abstract] [Full Text] [Related]

  • 20. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Mar 01; 35(3):796-805. PubMed ID: 15724243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.